University of Tokyo researchers have developed a novel selective catalyst that allows the creation of several basic chemicals from biomass instead of petroleum. This discovery may lead to the use of plant biomass as a basic feedstock for the chemical industry.
Researchers present an entirely new approach to tissue engineering that uses the interfacial forces between aqueous solutions of phase-separating polymers to confine cells and promote their assembly into interconnected, macroscopic tissue constructs. This simple and inexpensive general procedure creates free-standing, centimeter-scale constructs from cell suspensions in as little as 2 hours.
Benzodiazepine's introduction into clinical revolutionized the treatment of psychiatric disorders. Now, a research group of experts in preliminary drug discovery, has developed a succinct and efficient multicomponent-assisted synthetic methodology assembling unexplored benzodiazepine collections, thus, enabling to examine new areas of biological applications.
The first comprehensive computer model to simulate the development of blood cells could help in the development of new treatments for leukaemia and lymphoma, say researchers at the University of Cambridge and Microsoft Research.
Antibodies are now established as therapeutics and indispensable in the research lab. In contrast to high-quality therapeutics, commercial antibodies used in research often do not properly function. Researchers demand that antibodies used in research should be made by recombinant DNA technology - just like therapeutic antibodies.
Researchers bioengineered the microstructures to be the same size, shape and stiffness as adult heart muscle cells, or cardiomyocytes, with the goal of releasing biologically active peptides that act as cardioprotective agents.